Home » Products » Finerenone 20mg Tablets | GMP Manufacturer & Supplier | Sinophare
Product Description
| Product Name | Finerenone Tablets (Finerenone 20mg Oral Tablets) |
| Specification | Each tablet contains: Finerenone 20mg |
| Dosage Form | Oral Film-Coated Tablet (for oral administration) |
| Active Ingredient | Finerenone |
| Pharmacological Class | Non-Steroidal Mineralocorticoid Receptor Antagonist (MRA) |
| Route of Administration | Oral administration (swallowed whole with water; take at approximately the same time each day, with or without food). |
| Packaging | Blister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Shelf Life | 36 months (unopened) |
Product Overview
Finerenone Tablets is an oral preparation containing Finerenone 20mg per film-coated tablet. Finerenone is a non-steroidal mineralocorticoid receptor antagonist (MRA) that selectively blocks the mineralocorticoid receptor. It is used to reduce the risk of kidney disease progression and cardiovascular events in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes mellitus. Unlike steroidal MRAs such as spironolactone and eplerenone, finerenone is a non-steroidal compound with high selectivity for the mineralocorticoid receptor.
